Leukemia inhibitory factor maintains choline acetyltransferase expression in vivo

NeuroReport

Volumn 9, Issue 3, 1998, Pages 363-366

  Cheema, S S ^a   Arumugam, D ^a   Murray, S S ^a   Bartlett, P F ^b  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Axotomy; Choline acetyltransferase; Cholinergic; Leukemia inhibitory factor; LIF; P75NGFR

Indexed keywords

CHOLINE ACETYLTRANSFERASE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER TRANSECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION;

EID: 0032536349     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199802160-00001     Document Type: Article

References (30)

1. Murphy M, Reid K, Hilton DJ et al. Proc Natl Acad Sci USA 8, 498-501 (1991).
2. Martinou JC, Martionou I and Kato AC. Neuron, 8, 737-744 (1992).
3. Cheema SS, Richards LJ, Murphy M et al. J Neurosci Res 37, 213-218 (1994).
4. Cheema SS, Richards LJ, Murphy M et al. NeuroReport 5, 989-992 (1994).
5. Hughes RA, Sendtner M and Thoenen H. J Neurosci Res 36, 663-71 (1993).
6. Murphy M, Reid K, Brown MA et al. Development 117, 1173-82 (1993).
7. Hendry IA, Murphy M, Hilton DJ et al. J Neurosci 12, 3427-3434 (1992).
8. Curtis R, Scherer SS, Somogyi R et al. Neuron 12, 191-204 (1994).
9. Li M, Sendtner M and Smith A. Nature 378, 724-727 (1995).
10. Ikeda K, Iwanaki Y, Tagaya N et al. Muscle Nerve 18, 1344-1347 (1995).
11. Yamamori T, Fukada K, Aebersold R et al Science 248, 1412-1416 (1989).
12. Cervini R, Berrard S, Bejanin S et al. NeuroReport 6, 1346-1348 (1994).
13. Michikawa M, Kikuchi S and Kim SU. Neurosci Lett 140, 75-77 (1992).
14. Zurn AD and Werren F. Dev Biol 163, 309-315 (1994).
15. Kushima Y and Hatanaka H. Neurosci Lett 143, 110-114 (1992).
16. Richards LJ, Kilpatrick TJ, Bartlett PF et al. J Neurosci Res 33, 476-484 (1992).
17. Tuszynski MH, Amaral DG and Gage FL. J Neurosci 10, 3604-3614 (1990).
18. Widmer HR Knusel B and Hefti F. NeuroReport 4, 363-366 (1993).
19. Knusel B, Beck KO, Winslow JW et al. J Neurosci 12, 4391-4402 (1992).
20. Koliatsos VE, Applegate MD, Knusel B et al. Exp Neurol 112, 161-173 (1991).
21. Koliatsos VE, Clatterbuck RE, Nauta HJ et al. Ann Neurol 30, 831-840 (1991).
22. Morse JK, Wiegand SJ, Anderson K et al. J Neurosci 13, 4146-4156 (1993).
23. Hagg T, Quon D, Higaki J and Varon S. Neuron 8, 145-158 (1992).
24. Naumann T, Peterson GM and Frotscher M. J Comp Neur 325, 219-242 (1992).
25. Bartug RT, Dean RL, Beer B et al. Science 217, 408-417 (1982).
26. Coyle JT, Price DL and DeLong MR. Science 219, 1184-1189 (1983).
27. Rao MS, Tyrrell S, Landis SC and Patterson PH. Dev Biol 150, 281-293 (1992).
28. Ferguson IA, Schweitzer JB, Bartlett PF et al. J Comp Neurol 313, 680-692 (1991).
29. Yamakuni H, Minami M and Satoh M. J Neuroimmunol 70, 45-53 (1996).
30. Fusco M, Oderfeld-Nowak B, Vantini G et al. Neuroscience 33, 47-52 (1989).